Literature DB >> 20061628

Insulin-degrading enzyme sorting in exosomes: a secretory pathway for a key brain amyloid-beta degrading protease.

Ayelén Bulloj1, María C Leal, Huaxi Xu, Eduardo M Castaño, Laura Morelli.   

Abstract

The accumulation of amyloid-beta (Abeta) peptides in senile plaques is one of the hallmarks of Alzheimer's disease (AD) progression. The endocytic pathway has been proposed as a major subcellular site for Abeta generation while the compartments in which Abeta-degrading proteases interact with Abeta are still elusive. It was suggested that extracellular Abeta degradation may take place by plasma-membrane associated proteases or by extracellular proteases, among which insulin-degrading enzyme (IDE) is the most relevant. However, the mechanisms of IDE secretion are poorly understood. In the present study we used N2a cells to explore if IDE is indeed released through exosomes and the effect of exosomes release on extracellular levels of Abeta. We demonstrated that proteolytically-active plasma membrane associated-IDE is routed in living N2a cells to multivesicular bodies and subsequently, a major fraction is sorted to exosomes. We described that extracellular IDE levels decrease if the generation of multivesicular bodies is interfered and may be positively modulated by exosomes release under stress-induced conditions. Our results reinforce the relevance of functional IDE in the catabolism of extracellular Abeta.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20061628      PMCID: PMC4414343          DOI: 10.3233/JAD-2010-1206

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  59 in total

1.  Sorting of proteins into multivesicular bodies: ubiquitin-dependent and -independent targeting.

Authors:  F Reggiori; H R Pelham
Journal:  EMBO J       Date:  2001-09-17       Impact factor: 11.598

2.  Isolation and characterization of exosomes from cell culture supernatants and biological fluids.

Authors:  Clotilde Théry; Sebastian Amigorena; Graça Raposo; Aled Clayton
Journal:  Curr Protoc Cell Biol       Date:  2006-04

3.  Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains.

Authors:  A Pérez; L Morelli; J C Cresto; E M Castaño
Journal:  Neurochem Res       Date:  2000-02       Impact factor: 3.996

4.  Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation.

Authors:  Xian Zhang; Kun Zhou; Ruishan Wang; Jiankun Cui; Stuart A Lipton; Francesca-Fang Liao; Huaxi Xu; Yun-wu Zhang
Journal:  J Biol Chem       Date:  2007-02-15       Impact factor: 5.157

5.  TSAP6 facilitates the secretion of translationally controlled tumor protein/histamine-releasing factor via a nonclassical pathway.

Authors:  Nathalie Amzallag; Brent J Passer; David Allanic; Elodie Segura; Clotilde Théry; Bruno Goud; Robert Amson; Adam Telerman
Journal:  J Biol Chem       Date:  2004-08-19       Impact factor: 5.157

6.  Rise in cytoplasmic Ca2+ induced by monensin in bovine medullary chromaffin cells.

Authors:  V Nassar-Gentina; E Rojas; M Luxoro
Journal:  Cell Calcium       Date:  1994-12       Impact factor: 6.817

Review 7.  Autophagy, amyloidogenesis and Alzheimer disease.

Authors:  Ralph A Nixon
Journal:  J Cell Sci       Date:  2007-12-01       Impact factor: 5.285

8.  The catalytic domain of insulin-degrading enzyme forms a denaturant-resistant complex with amyloid beta peptide: implications for Alzheimer disease pathogenesis.

Authors:  Ramiro E Llovera; Matías de Tullio; Leonardo G Alonso; Malcolm A Leissring; Sergio B Kaufman; Alex E Roher; Gonzalo de Prat Gay; Laura Morelli; Eduardo M Castaño
Journal:  J Biol Chem       Date:  2008-04-14       Impact factor: 5.157

9.  Amino acid sequence of rabbit kidney neutral endopeptidase 24.11 (enkephalinase) deduced from a complementary DNA.

Authors:  A Devault; C Lazure; C Nault; H Le Moual; N G Seidah; M Chrétien; P Kahn; J Powell; J Mallet; A Beaumont
Journal:  EMBO J       Date:  1987-05       Impact factor: 11.598

10.  Insulin-degrading enzyme is exported via an unconventional protein secretion pathway.

Authors:  Ji Zhao; Lilin Li; Malcolm A Leissring
Journal:  Mol Neurodegener       Date:  2009-01-14       Impact factor: 14.195

View more
  64 in total

Review 1.  Multivesicular bodies in neurons: distribution, protein content, and trafficking functions.

Authors:  Christopher S Von Bartheld; Amy L Altick
Journal:  Prog Neurobiol       Date:  2011-01-07       Impact factor: 11.685

Review 2.  Hepatic Insulin Clearance: Mechanism and Physiology.

Authors:  Sonia M Najjar; Germán Perdomo
Journal:  Physiology (Bethesda)       Date:  2019-05-01

3.  Statins promote the degradation of extracellular amyloid {beta}-peptide by microglia via stimulation of exosome-associated insulin-degrading enzyme (IDE) secretion.

Authors:  Irfan Y Tamboli; Esther Barth; Leonie Christian; Martin Siepmann; Sathish Kumar; Sandesh Singh; Karen Tolksdorf; Michael T Heneka; Dieter Lütjohann; Patrick Wunderlich; Jochen Walter
Journal:  J Biol Chem       Date:  2010-09-28       Impact factor: 5.157

Review 4.  Exosomes: a new weapon to treat the central nervous system.

Authors:  Luca Braccioli; Cindy van Velthoven; Cobi J Heijnen
Journal:  Mol Neurobiol       Date:  2013-07-16       Impact factor: 5.590

5.  Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease.

Authors:  Michael B Dinkins; Somsankar Dasgupta; Guanghu Wang; Gu Zhu; Erhard Bieberich
Journal:  Neurobiol Aging       Date:  2014-02-15       Impact factor: 4.673

6.  Curcumin Ameliorates Memory Decline via Inhibiting BACE1 Expression and β-Amyloid Pathology in 5×FAD Transgenic Mice.

Authors:  Kunmu Zheng; Xiaoman Dai; Nai'an Xiao; Xilin Wu; Zhen Wei; Wenting Fang; Yuangui Zhu; Jing Zhang; Xiaochun Chen
Journal:  Mol Neurobiol       Date:  2016-02-24       Impact factor: 5.590

Review 7.  Targeting Insulin-Degrading Enzyme to Treat Type 2 Diabetes Mellitus.

Authors:  Wei-Jen Tang
Journal:  Trends Endocrinol Metab       Date:  2015-12-02       Impact factor: 12.015

Review 8.  Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy.

Authors:  Natalia N Nalivaeva; Anthony J Turner
Journal:  Br J Pharmacol       Date:  2019-03-11       Impact factor: 8.739

9.  Phosphorylation of amyloid-β peptide at serine 8 attenuates its clearance via insulin-degrading and angiotensin-converting enzymes.

Authors:  Sathish Kumar; Sandesh Singh; Désirée Hinze; Michaele Josten; Hans-Georg Sahl; Martin Siepmann; Jochen Walter
Journal:  J Biol Chem       Date:  2012-01-20       Impact factor: 5.157

Review 10.  Sphingolipid-Enriched Extracellular Vesicles and Alzheimer's Disease: A Decade of Research.

Authors:  Michael B Dinkins; Guanghu Wang; Erhard Bieberich
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.